Inventaire - dina vänner och gemenskaper är ditt bästa bibliotek

Phase II trial of 131I-B1 (anti-CD20) antibody therapy with autologous stem cell transplantation for relapsed B cell lymphomas.

författare

Oliver W Press

Frederick R. Appelbaum

publicerad i: The Lancet

utgivningsår: 1995-08-01

språk: engelska

huvudämne: phase II clinical trial, antikropp

Refererar artiklar 23

Datum

Titel

Författare

1994-06-01

Myeloablative therapy with autologous bone marrow transplantation as consolidation therapy for recurrent follicular lymphoma
1994-12-01

Fractionated total-body irradiation, etoposide, and cyclophosphamide plus autografting in Hodgkin's disease and non-Hodgkin's lymphoma

Gwynn D Long, Robert S. Negrin
1994-12-01

High-dose fractionated total-body irradiation, etoposide, and cyclophosphamide followed by autologous stem-cell support in patients with malignant lymphoma.

Frederick R. Appelbaum, Hans Joachim Deeg
1994-06-01

ESHAP--an effective chemotherapy regimen in refractory and relapsing lymphoma: a 4-year follow-up study
1993-02-01

Veno-occlusive disease of the liver and multiorgan failure after bone marrow transplantation: a cohort study of 355 patients
1993-10-01

Radiolabeled-antibody therapy of B-cell lymphoma with autologous bone marrow support

Frederick R. Appelbaum
1993-08-01

Radioimmunotherapy of B-cell lymphoma with [131I]anti-B1 (anti-CD20) antibody
1993-10-01

Phase I dose-escalation trial of iodine 131-labeled monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma

Lloyd J. Old
1993-10-01

Which patients with relapsed non-Hodgkin's lymphoma benefit from high-dose therapy and hematopoietic stem-cell transplantation?

Lee M. Nadler
1992-01-01

The multichain interleukin-2 receptor: a target for immunotherapy
1991-06-01

Phase I-II studies of yttrium-labeled antiferritin treatment for end-stage Hodgkin's disease, including Radiation Therapy Oncology Group 87-01
1991-04-01

Targeting, dosimetry, and radioimmunotherapy of B-cell lymphomas with iodine-131-labeled LL2 monoclonal antibody
1990-05-01

Autologous bone marrow transplantation in B-cell non-Hodgkin's lymphoma: very low treatment-related mortality in 100 patients in sensitive relapse
1990-04-01

Autologous marrow transplantation for malignant lymphoma: a report of 101 cases from Seattle

Rainer Storb, Frederick R. Appelbaum
1990-05-01

A phase I toxicity, pharmacology, and dosimetry trial of monoclonal antibody OKB7 in patients with non-Hodgkin's lymphoma: effects of tumor burden and antigen expression

Lloyd J. Old, Herbert F. Oettgen, Pilar Garin-Chesa
1989-11-01

Report of a committee convened to discuss the evaluation and staging of patients with Hodgkin's disease: Cotswolds meeting

Eli J. Glatstein
1989-08-01

Treatment of refractory non-Hodgkin's lymphoma with radiolabeled MB-1 (anti-CD37) antibody

Oliver W Press, Frederick R. Appelbaum
1988-10-01

Regimen-related toxicity in patients undergoing bone marrow transplantation

Edward Donnall Thomas, C. Dean Buckner, Frederick R. Appelbaum
1988-03-01

Mechanical ventilation after marrow transplantation. Risk factors and clinical outcome
1987-09-01

Treatment of malignant lymphoma in 100 patients with chemotherapy, total body irradiation, and marrow transplantation.

C. Dean Buckner, Frederick R. Appelbaum, Hans Joachim Deeg
1987-06-01

Durable remissions in stage III follicular lymphoma: interpret with caution
1985-10-01

Isotopic immunoglobulin: a new systemic therapy for advanced Hodgkin's disease
Preliminary validation of the opposing view method for quantitative gamma camera imaging

Artikel - wd:Q44656909

Välkommen till Inventaire

din gemenskap och vänners bibliotek

lär mer